Globus Medical, Inc. (GMED) Revenue by Segment

Executive TeamFinancialsSegments
Shareholders

Globus Medical revenue by segment at a glance

In Q2 fiscal 2026 (the quarter ended June 30, 2026), Globus Medical's largest product or service was Musculoskeletal Solutions, with $763.54 million or 97% of revenue, up 7.5% from a year earlier. Next: Enabling Technologies (3%).

By region, United States brought in 78% and Non-US brought in 22% of revenue in Q2 fiscal 2026.

From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

GMED logo

Globus Medical, Inc.

GMEDUnited States
Healthcare

Revenue breakdown

Fiscal quarters, from company filings

Globus Medical revenue by product or service, last 4 quarters

Product or serviceQ2 FY26Q1 FY26Q3 FY25Q2 FY25Share
Musculoskeletal Solutions$763.5M$733.0M–$710.2M97%
Enabling Technologies$26.1M$26.9M–$35.2M3%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Globus Medical revenue by region, last 4 quarters

RegionQ2 FY26Q1 FY26Q3 FY25Q2 FY25Share
United States$619.1M$604.9M$617.6M$600.8M78%
Non-US$170.5M$155.0M$151.4M$144.6M22%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Questions and answers

Which product or service makes the most money for Globus Medical?

Musculoskeletal Solutions: $763.54 million, or 97% of revenue, in Q2 fiscal 2026.

What are Globus Medical's main products and services?

By revenue in Q2 fiscal 2026: Musculoskeletal Solutions (97%) and Enabling Technologies (3%).

Where does Globus Medical make its money?

By region in Q2 fiscal 2026: United States (78%) and Non-US (22%).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube